Published Date:2021-09-02
Original Link:https://www.onenessbio.com/en/news_detail54_2.htm
| No | 1 | Date of announcement | 2021/09/02 | Time of announcement | 17:24:08 |
|---|---|---|---|---|---|
| Subject | Oneness Biotech Co., LTD receives a Japanese patent on OB318, a new drug in development for liver cancer. | ||||
| To which item it meets |
paragraph 53 | Date of events | 2021/09/02 | ||
| Statement | |||||
|
1.Date of occurrence of the event:2021/09/02
2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence:OB318 has been granted a Japanese patent titled ”COMPOUNDS FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF” under patent number 6896630. 6.Countermeasures:None 7.Any other matters that need to be specified:OB318 has obtained patents titled ”COMPOUNDS FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF” in Taiwan, the U.S., Europe, Malaysia and China. |
|||||